Citadel Advisors - BIOLINERX LTD ownership

BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 26 filers reported holding BIOLINERX LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BIOLINERX LTD
ValueSharesWeighting
Q1 2019$14,000
-46.2%
33,531
-42.6%
0.00%
Q4 2018$26,000
+136.4%
58,376
+346.3%
0.00%
Q1 2018$11,000
-54.2%
13,081
-40.1%
0.00%
Q4 2017$24,000
+84.6%
21,820
+91.9%
0.00%
Q3 2017$13,000
-87.3%
11,371
-89.3%
0.00%
Q1 2017$102,000
+466.7%
105,986
+443.4%
0.00%
Q4 2016$18,000
-5.3%
19,505
+18.6%
0.00%
Q3 2016$19,000
-73.6%
16,448
-49.2%
0.00%
Q1 2014$72,00032,3730.00%
Other shareholders
BIOLINERX LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Senvest Management, LLC 3,543,300$2,835,0000.23%
Opaleye Management Inc. 250,000$223,0000.15%
Benchmark Capital Advisors 44,000$35,0000.03%
MENTA CAPITAL LLC 98,647$79,0000.01%
NEXT Financial Group, Inc 39,500$31,0000.01%
Cutter & CO Brokerage, Inc. 25,000$20,0000.01%
Orbimed Advisors 1,038,600$831,0000.01%
TWO SIGMA SECURITIES, LLC 17,771$14,0000.01%
Alyeska Investment Group, L.P. 611,947$490,0000.01%
A.R.T. Advisors, LLC 25,890$20,0000.00%
View complete list of BIOLINERX LTD shareholders